Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerwin Huls

Showing results (51-60 of 162) with videos related to

Pageof 17
Sort By:
Cancers|January 8, 2023
High <i>ME1</i> Expression Is a Molecular Predictor of Post-Transplant Survival of Patients with Acute Myeloid LeukemiaCésar Alexander Ortiz Rojas, Abel Costa-Neto, Diego A Pereira-Martins, et al.
Experimental Hematology|November 29, 2011
Treatment with high-dose simvastatin inhibits geranylgeranylation in AML blast cells in a subset of AML patientsKaren van der Weide, Susan de Jonge-Peeters, Gerwin Huls, et al.
Cancers|November 10, 2019
WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA DamageMathilde Rikje Willemijn de Jong, Myra Langendonk, Bart Reitsma, et al.
Plos One|August 18, 2017
Pilot study of lithium to restore intestinal barrier function in severe graft-versus-host diseaseGideon Steinbach, David M Hockenbery, Gerwin Huls, et al.
Molecular Therapy. Oncology|July 1, 2025
K12-ligand-based CAR T cell therapy for CD7-positive T cell malignanciesNienke Visser, Macarena González-Corrales, Jimena Álvarez-Freile, et al.
Mayo Clinic Proceedings|March 6, 2018
Active Smoking and Hematocrit and Fasting Circulating Erythropoietin Concentrations in the General PopulationMichele F Eisenga, Lyanne M Kieneker, Daan J Touw, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 9, 2026
Selective Targeting of Immune Checkpoints HLA-G and CD47 Using Novel Dual Signaling Protein DSP216 Promotes Innate Anticancer ImmunityLisa J Jacob, Liat Tamir, Mufeed Abdeen, et al.
Nature Communications|February 3, 2019
Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosisYuan He, Renee Bouwstra, Valerie R Wiersma, et al.
European Journal of Haematology|July 9, 2025
Patients With Relapsed Large B-Cell Lymphoma After 12 Months Have a Similarly Poor Prognosis to Those Relapsing Within 12 MonthsHilde T van der Galiën, Hilde A M Kooistra, Robby Kibbelaar, et al.
Haematologica|May 30, 2013
A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysisCarolien M Woolthuis, André B Mulder, Rikst Nynke Verkaik-Schakel, et al.
Pageof 17

Showing results (51-60 of 162) with videos related to

Sort By:
Pageof 17
Cancers|January 8, 2023
High <i>ME1</i> Expression Is a Molecular Predictor of Post-Transplant Survival of Patients with Acute Myeloid LeukemiaCésar Alexander Ortiz Rojas, Abel Costa-Neto, Diego A Pereira-Martins, et al.
Experimental Hematology|November 29, 2011
Treatment with high-dose simvastatin inhibits geranylgeranylation in AML blast cells in a subset of AML patientsKaren van der Weide, Susan de Jonge-Peeters, Gerwin Huls, et al.
Cancers|November 10, 2019
WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA DamageMathilde Rikje Willemijn de Jong, Myra Langendonk, Bart Reitsma, et al.
Plos One|August 18, 2017
Pilot study of lithium to restore intestinal barrier function in severe graft-versus-host diseaseGideon Steinbach, David M Hockenbery, Gerwin Huls, et al.
Molecular Therapy. Oncology|July 1, 2025
K12-ligand-based CAR T cell therapy for CD7-positive T cell malignanciesNienke Visser, Macarena González-Corrales, Jimena Álvarez-Freile, et al.
Mayo Clinic Proceedings|March 6, 2018
Active Smoking and Hematocrit and Fasting Circulating Erythropoietin Concentrations in the General PopulationMichele F Eisenga, Lyanne M Kieneker, Daan J Touw, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 9, 2026
Selective Targeting of Immune Checkpoints HLA-G and CD47 Using Novel Dual Signaling Protein DSP216 Promotes Innate Anticancer ImmunityLisa J Jacob, Liat Tamir, Mufeed Abdeen, et al.
Nature Communications|February 3, 2019
Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosisYuan He, Renee Bouwstra, Valerie R Wiersma, et al.
European Journal of Haematology|July 9, 2025
Patients With Relapsed Large B-Cell Lymphoma After 12 Months Have a Similarly Poor Prognosis to Those Relapsing Within 12 MonthsHilde T van der Galiën, Hilde A M Kooistra, Robby Kibbelaar, et al.
Haematologica|May 30, 2013
A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysisCarolien M Woolthuis, André B Mulder, Rikst Nynke Verkaik-Schakel, et al.
Pageof 17